https://www.indianpharmapost.com/ema-grants-orphan-drug-status-to-sanofis-efdoralprin-alfa-for-rare-lung-disease-186142025-12-20T00:00:00+05:30always0.9https://www.indianpharmapost.com/briefs-apl-healthcare-biocon-usfda-sun-pharma-and-clean-fino-chem-186152025-12-20T00:00:00+05:30always0.9https://www.indianpharmapost.com/cosette-pharmaceuticals-launches-first-generic-cipro-hc-with-180-days-market-exclusivity-186162025-12-20T00:00:00+05:30always0.9https://www.indianpharmapost.com/gsks-exdensur-gains-fda-nod-for-severe-asthma-with-just-two-doses-a-year-186172025-12-20T00:00:00+05:30always0.9https://www.indianpharmapost.com/sandboxaq-maplight-team-up-to-target-novel-cns-therapy-with-ai-driven-drug-discovery-186182025-12-20T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizer-and-cipla-forge-exclusive-marketing-and-distribution-pact-for-key-brands-in-india-186192025-12-20T00:00:00+05:30always0.9https://www.indianpharmapost.com/fortis-invests-rs-840-crore-for-300-beds-in-bengaluru-186202025-12-20T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-announces-usfda-final-approval-for-travoprost-ophthalmic-solution-usp-0004-186212025-12-20T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-signs-exclusive-agreement-with-myriad-genetics-of-us-to-launch-cancer-risk-assessment-diagnostic-tests-in-india-186222025-12-20T00:00:00+05:30always0.9